Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find a new pharmacological target to modulate the effect of cannabinoids through their CB1 receptors

05.07.2012
A group or researchers from the Faculty of Biology of the University of Barcelona and the Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), a centre for biomedical network research on neurodegenerative diseases dependant on the Ministry of Economics and Competitiveness through the Carlos III Health Institute, has shown, in a research published in the Journal of Biological Chemistry, the expression of complexes known as heteromerswithin the cannabinoid receptors CB2 and CB1.
The results of this research may help in the better understanding of alterations where the CB1 receptor participates, such as in chronic pain, Parkinson's disease, cerebral trauma or brain tumours in which there may be a high inflammatory component.

Cannabis, commonly known as marihuana, is one of the most widely abused drugs among the European population. Its psychoactive substances act by interacting with proteins from the membrane of the cells which are their CB1 and CB2 receptors. In a natural way and independent of the marihuana, the cells themselves release compounds which are called endocannabinoids and they activate the CB1 and CB2 receptors to produce a physiological response.

The CB1 cannabinoid receptor is one of the most abundant receptors in the brain and it helps to regulate movement, as well as functioning as a therapeutic target for the treatment of pain, inflammation and Parkinson's disease, and it alleviates some side effects in cancer patients. Nevertheless, the CB2 cannabinoid receptors are far from being abundant in the brain and their function is not completely clear. This makes these receptors a subject of scientific interest, precisely because of the scarcity of information regarding their functioning.

The existence and function of the CB2 receptors in the neurons has always been controversial. This new research now offers two relevant conclusions: in the first place, the expression of CB2 as a protein in the neurons is confirmed and, in the second place, it is shown that the CB2 receptors may be a new pharmacological target for the modulation of the effect of cannabinoids through the CB1 receptor, forming CB1-CB2 heteromers which are expressed in the brain. The mission of CB2 in these heteromers is to repress the CB1 receptors, which could explain that during processes of inflammation, the CB2 receptors act as a brake on the CB1 receptors.

The research shows that it is necessary to take these heteromers into account for the effective design of medicines to counteract cannabinoid receptors, since these heteromers are the real targets and they show properties that are different from the individual receptors. This project has been carried out by the Molecular Neurobiology Research Group from the University of Barcelona, integrated in the campus of international excellence Barcelona Knowledg Campus (BKC), and the following lecturers worked on it: Dr. Peter McCormick, Dr. Enric I. Canela, Dr. Antoni Cortés, Dr. Carme Lluís, Dr. Josefa Mallol, Dr. Vicent Casadó, Dr. David Moreno-Delgado and Dr. Estefanía Moreno and the doctoral student Lucía Callén. Also participating in the project were Dr. José Luis Lanciego and Dr. Rafael Franco from the University of Navarra.

Parkinson's disease affects around 70,000 people in Spain

Neurodegenerative diseases (NDD) represent one of the most important health challenges in developed countries, because of their consequences for health and quality of life of those who suffer from them, as well as the socioeconomic burden that they represent. They are generally chronic, for the moment incurable, diseases and their common denominator is the death of neurons in different regions of the nervous system, which leads to the functional deterioration of the affected parts. In the case of Parkinson's disease, there are 70,000 people affected in Spain and the disease is characterized principally by the loss of neurons and the formation of Lewy bodies and Lewy neurites in the black substance and the consequent loss of striatal dopamine (DA). Nevertheless, it is currently well known that Parkinson's disease is a multisystemic neurodegenerative process, in which, as the neurodegenerative process evolves, numerous regions of the nervous system are affected and there exists a deficit in various systems of neurotransmission and neuromodulation.

The Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) is one of the reference centres in Spain for research on neurodegenerative diseases (NDD), such as Alzheimer’s, Parkinson’s, Huntington’s diseases and other ataxias and neuromuscular diseases. It was created in 2006 and its main objective is to promote basic biomedical, clinical and epidemiological research, as well as to ensure that the research carried out in laboratories can be put into practice and reach the patient (translational research). Legally it is organised as a public consortium where various institutions representing the Spanish General State Administration, the Spanish Autonomous Communities and other non-institutional organisations take part. It gathers a total of 58 Spanish research groups that share a common goal: the fight against neurodegeneration.
Bibliographische AngabenCannabinoid Receptors CB1 and CB2 Form Functional
Heteromers in Brain. Lucía Callén, Estefanía Moreno, Pedro Barroso-Chinea, David Moreno-Delgado, Antoni Cortés,

Josefa Mallol, Vicent Casadó, José Luis Lanciego, Rafael Franco, Carmen Lluis, Enric I. Canela, and Peter J. McCormick.

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 25, pp. 20851–20865, June 15, 2012

Hinweise an die RedaktionFurther information:

Dr. Peter McCormick
Dept. Bioquímica i Biologia Molecular (Biologia)
Facultat de Biologia - UNIVERSITAT DE BARCELONA
Tf 00 34 934039280
mailto: pmccormick@ub.edu

Rosa Martínez | alfa
Further information:
http://www.ub.edu

More articles from Life Sciences:

nachricht Order from noise: how randomness and collective dynamics define a stem cell
06.07.2020 | Institute of Science and Technology Austria

nachricht Rising water temperatures could endanger the mating of many fish species
03.07.2020 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electrons in the fast lane

Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.

Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....

Im Focus: The lightest electromagnetic shielding material in the world

Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range – and they are unrivalled in terms of weight.

Electric motors and electronic devices generate electromagnetic fields that sometimes have to be shielded in order not to affect neighboring electronic...

Im Focus: Gentle wall contact – the right scenario for a fusion power plant

Quasi-continuous power exhaust developed as a wall-friendly method on ASDEX Upgrade

A promising operating mode for the plasma of a future power plant has been developed at the ASDEX Upgrade fusion device at Max Planck Institute for Plasma...

Im Focus: ILA Goes Digital – Automation & Production Technology for Adaptable Aircraft Production

Live event – July 1, 2020 - 11:00 to 11:45 (CET)
"Automation in Aerospace Industry @ Fraunhofer IFAM"

The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM l Stade is presenting its forward-looking R&D portfolio for the first time at...

Im Focus: AI monitoring of laser welding processes - X-ray vision and eavesdropping ensure quality

With an X-ray experiment at the European Synchrotron ESRF in Grenoble (France), Empa researchers were able to demonstrate how well their real-time acoustic monitoring of laser weld seams works. With almost 90 percent reliability, they detected the formation of unwanted pores that impair the quality of weld seams. Thanks to a special evaluation method based on artificial intelligence (AI), the detection process is completed in just 70 milliseconds.

Laser welding is a process suitable for joining metals and thermoplastics. It has become particularly well established in highly automated production, for...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International conference QuApps shows status quo of quantum technology

02.07.2020 | Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

 
Latest News

Order from noise: how randomness and collective dynamics define a stem cell

06.07.2020 | Life Sciences

Lighting array in the ear: First use of multi-channel cochlear implants with microscale light-emitting diodes

06.07.2020 | Medical Engineering

Genetic code for stem cell heart repair detected

06.07.2020 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>